Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Lijie Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-5794-0165; OpenAlex author ID A5102985432. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. LINC01137 facilitates pancreatic cancer stemness, chemoresistance and proliferation via the miR-7155-5p/KLF12/PI3K-Akt axis. Co-author DOI 10.1016/j.ijbiomac.2026.150088↗
  2. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability. Co-author DOI 10.1186/s12967-023-04702-6↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhichong Wu · 2 shared papers, 2023–2026 · strength 0.41
  2. Zengyu Feng · 1 shared paper, 2026 · strength 0.24
  3. Kexian Li · 1 shared paper, 2026 · strength 0.24
  4. Chenghong Peng · 1 shared paper, 2026 · strength 0.24
  5. Yizhi Cao · 1 shared paper, 2026 · strength 0.24
  6. Xiaxing Deng · 1 shared paper, 2026 · strength 0.24
  7. Kai Qin · 1 shared paper, 2026 · strength 0.24
  8. Cheng Xiong · 1 shared paper, 2023 · strength 0.16
  9. Ting Wang · 1 shared paper, 2023 · strength 0.16
  10. Lingxi Jiang · 1 shared paper, 2023 · strength 0.16
  11. Xiaozhu Lin · 1 shared paper, 2023 · strength 0.16
  12. Youwei Zhu · 1 shared paper, 2023 · strength 0.16
  13. Meilin Xue · 1 shared paper, 2023 · strength 0.16
  14. Hao Chen · 1 shared paper, 2023 · strength 0.16
  15. Baiyong Shen · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.